4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-071909
President, CEO sold 15,000 shares at an average $45.42 ($681,277)
- President, CEO acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobs John C President, CEO | 2022-06-15 | Option exercise | +15,000 | $8.22 | $123,300 | 15,000 | D: show line 1 in the form |
| Jacobs John C President, CEO | 2022-06-15 | Sale | −14,200 | $45.38 | $644,370 | 800 | D: show line 2 in the form |
| Jacobs John C President, CEO | 2022-06-15 | Sale | −800 | $46.13 | $36,907 | 0 | D: show line 3 in the form |
| Open-market sales · 15,000 sh · avg $45.42 · $681,277 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Jacobs John C President, CEO | 2022-06-15 | Option exercise · Stock Option | −15,000 | 154,751 | D: show line 4 in the form |
Loading xslF345X03/tm2218582-1_4seq1.xml…